Is BioLargo, Inc. (BLGO) a Buy, Sell, or Hold?
OTC : BLGO
BioLargo, Inc.
$0.10638 USD
$0.0 (-3.29%)
- Volume
- 16.16K
- Average Volume
- 375.63K
- Market Capitalization
- $34.14M
- P/E Ratio
- -2.63
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $0.23
- Year Low
- $0.10
- Day High
- —
- Day Low
- —
- Payout Ratio
- -$0.03
- Current Ratio
- $1.10
Company Overview
OTC
Dennis Calvert
Chemicals
Basic Materials
BLGO
45
US
USD
Liquidity Metrics
3.17
1.10
1.04
0.84
-0.03
Sales & Valuation
$7.76M
6.08
18.98
-3.61
-0.03
Profitability
-$0.0384
-$11.78M
-230.08%
-297.15%
-244.01%
-150.73%
P/E Metrics
-2.63
0.02
0.02
Analyst Price Target & Rating
1/5
0 Analysts
%
Financial Health Scores
-29.83
1/9
$513K
$8.56M
$8.75M
-$16.19M
Key Metrics (TTM)
$36.83M
6.56
-2.32
1.10
-244.01%
-295.74%
-36.83%
-26.81%
-65 days
Company Executives
| Name | Title |
|---|---|
| Steven V. Harrison | President of Clyra Medical Technologies Inc |
| Randall Moore | President of BioLargo Engineering, Science & Technologies, LLC |
| Tonya Chandler | President of BioLargo Equipment Solutions & Technologies |
| Charles K. Dargan | Chief Financial Officer |
| Richard Smith | President of BioLargo Water |
| Joseph L. Provenzano | Executive Vice President of Operations, Corporate Secretary & Director |
| Dennis Calvert | Chairman, President & Chief Executive Officer |
| Kenneth Reay Code | Chief Science Officer & Director |
Poll Results
No votes yet today — be the first to share your view!
About BioLargo, Inc. (OTC:BLGO) Stock
BioLargo, Inc. pioneers the invention, development, and commercialization of sophisticated platform technologies. The company is dedicated to tackling critical environmental challenges, such as per- and polyfluoroalkyl substances (PFAS) contamination, advanced water and wastewater purification, managing industrial odors and volatile organic compounds (VOCs), enhancing air quality, and controlling infections. Backed by numerous issued patents, BioLargo maintains a robust product pipeline and extends its expertise through comprehensive environmental engineering services. Among its notable innovations are the Advanced Oxidation system, a water treatment solution generating potent oxidative and energetic iodine species; the Aqueous Electrostatic Concentrator, specifically designed for eliminat ... ing PFAS from water; CupriDyne Clean industrial products, which effectively neutralize stubborn odors and VOCs across various industrial settings; and specialized advanced wound care products. Established in 1991, BioLargo, Inc. is headquartered in Westminster, California.
2026-08-03 06:00:00
The patented AEC removes more than 99% of PFAS chemicals in water, consistently exceeding state and federal requirements, and generates a fraction of the waste of conventional methods. WESTMINSTER, CA / ACCESS Newswire / August 3, 2026 / BioLargo, Inc. (OTCQX:BLGO), an environmental engineering company developing and commercializing sustainable technologies, today announced that its patented Aqueous Electrostatic Concentrator (AEC) has treated more than two million gallons of PFAS-contaminated water in over six months of sustained commercial service at the municipal drinking water facility in Lake Stockholm, New Jersey.
2026-07-30 09:00:00
Company to contribute commercial PFAS treatment expertise alongside leading universities, regulators, utilities, and industry organizations advancing next-generation PFAS solutions. WESTMINSTER, CA / ACCESS Newswire / July 30, 2026 / BioLargo, Inc. (OTCQX:BLGO), a cleantech and life sciences innovator and engineering services and solution provider, announced that it has joined the New Jersey PFAS Partnership Innovation Consortium (NJ PFAS-PIC), an NJIT-led initiative focused on accelerating the development, validation, and deployment of PFAS technologies.
2026-07-29 08:00:00
Tonya Chandler will lead a seven-hour continuing education course for the fourth consecutive year at one of the water industry's largest regional gatherings WESTMINSTER, CA / ACCESS Newswire / July 29, 2026 / BioLargo, Inc. (OTCQX:BLGO), a cleantech and life sciences innovator that creates and commercializes sustainable technologies to solve tough environmental challenges, announced that Tonya Chandler, will lead a workshop titled "PFAS 101 - Everything You Didn't Want to Know About PFAS" at the 41st Annual Tri-State Seminar on Monday, August 3, 2026, from 7:30 a.m. to 4:00 p.m.
BioLargo PFAS Treatment Technology Featured in The Disruptive Quarterly
2026-07-27 06:00:00
Company leaders join environmental attorneys, academic researchers, and industry innovators in a special issue on forever chemicals and the protection of clean water WESTMINSTER, CA / ACCESS Newswire / July 27, 2026 / BioLargo, Inc. (OTCQX:BLGO), a cleantech and life sciences innovator, today announced the publication of the Q1/Q2 2026 edition of The Disruptive Quarterly (TDQ), titled "Water and Our Common Heritage: Facing the Challenge of Forever Chemicals." This latest TDQ edition brings together environmental attorneys, academic researchers, industry innovators, and artists around a single theme: protecting clean water in the face of PFAS contamination.
2026-07-13 10:30:00
BioLargo's newly formed subsidiary, BioLargo CPG, will bring to consumers the authentic, independently safety-tested CupriDyne® technology under its own brand following the marketing success of the original Pooph products that generated more than $125 million in pet-care sales while under license from BioLargo. WESTMINSTER, CA / ACCESS Newswire / July 13, 2026 / BioLargo, Inc. (OTCQX:BLGO) today announced that it is preparing to relaunch CupriDyne®-based consumer pet products under a yet-to-be-announced brand.
BioLargo Engineering Unit Awarded $1.4 Million in U.S. Air Force Environmental Contract Renewals
2026-07-01 06:00:00
BLEST Renews Air Quality Compliance Work at Five Air Force Bases Across New Mexico and Arizona WESTMINSTER, CA / ACCESS Newswire / July 1, 2026 / BioLargo, Inc. (OTCQX:BLGO), a cleantech and life sciences innovator and engineering services solution provider, today announced that its engineering subsidiary, BioLargo Engineering, Science & Technologies (BLEST), has received contract renewals totaling more than $1.4 million over 12 months to continue providing air quality and environmental support services at five U.S. Air Force bases. BLEST serves as a subcontractor to the primary environmental contractors and performs regulatory compliance, permitting, testing, air data management, compliance reporting, and inventory management.
Frequently Asked Questions
-
What is the current BioLargo, Inc. (BLGO) stock price?
-
BioLargo, Inc.(OTC:BLGO) stock price is $0.10638 in the last trading session. During the trading session, BLGO stock reached the peak price of $0.23 while $0.1 was the lowest point it dropped to. The percentage change in BLGO stock occurred in the recent session was --3.29% while the dollar amount for the price change in BLGO stock was -$0.0.
-
BLGO's industry and sector of operation?
-
The OTC listed BLGO is part of Chemicals industry that operates in the broader Basic Materials sector.
-
Who are the executives of BLGO?
-
Steven V. Harrison | President of Clyra Medical Technologies Inc
Randall Moore | President of BioLargo Engineering, Science & Technologies, LLC
Tonya Chandler | President of BioLargo Equipment Solutions & Technologies
Charles K. Dargan | Chief Financial Officer
Richard Smith | President of BioLargo Water -
How many employees does BLGO have?
-
Number of BLGO employees currently stands at 45. BLGO operates from 14921 Chestnut Street, Westminster, CA 92683, US.
-
Link for BLGO official website?
-
Official Website of BLGO is: https://www.biolargo.com
-
How do I contact BLGO?
-
BLGO could be contacted at phone #888 400 2863 and can also be accessed through its website. BLGO operates from 14921 Chestnut Street, Westminster, CA 92683, US.
-
How many shares of BLGO are traded daily?
-
The average number of BLGO shares traded daily for last 3 months was 375.63K.
-
What is the market cap of BLGO currently?
-
The market value of BLGO currently stands at $34.14M with its latest stock price at $0.10638